NEOS launches the MSCI EAFE High Income ETF (NIHI), combining global equity exposure with a call-writing strategy to deliver monthly income and tax perks.
With the iPhone 17 officially out from Apple, here's a look back at how much past models were priced at and how much investors would have made buying stock instead.
Vanguard debuts its first high-yield active ETF, VGHY, offering flexible bond exposure at a low 0.22% expense ratio, backed by its $1T fixed income team.
Faraday Future Intelligent Electric Inc (NASDAQ:FFAI) isn't shy about its ambitions—or its eclectic playbook. After more than a decade and $4 billion invested in tech, the California-based EV maker is pitching itself as Tesla 2.0, only with a celebrity sheen and a crypto kicker.
The financial markets in 2025 are undeniably captivated by Artificial Intelligence, with AI-driven stocks experiencing a meteoric rise that has propelled major indices to unprecedented heights. This overwhelming bullish sentiment has firmly established AI as the preeminent growth driver, fundamentally reshaping investment landscapes and sparking a fervent debate: Is the
According to a CNBC report on Thursday, Durant’s agent, Rich Kleiman, said at CNBC’s Game Plan conference in Los Angeles that the NBA superstar’s team has not been able to track down Durant’s Coinbase account information.
Looking for the most active stocks in the S&P500 index on Friday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market.
Netflix (NASDAQ: NFLX) has firmly planted its flag in the competitive landscape of live sports broadcasting, achieving unprecedented global viewership with its recent boxing event featuring social media sensation Jake Paul and boxing legend Mike Tyson. The highly anticipated November 15, 2024, bout drew an estimated average minute audience of
Hasbro and Target gain from booming trading-card demand, while Mattel's sales skew toward a tighter, holiday-heavy Q4 amid cautious retailer inventories.
Netflix (NASDAQ: NFLX) is currently undergoing a significant executive reorganization, marked by recent high-profile departures and strategic internal realignments. These changes unfold against a backdrop of rapid advancements in artificial intelligence, which is increasingly reshaping content creation and intensifying competition within the film and streaming industries. The streaming giant's proactive
Eli Lilly (NYSE: LLY) is poised to further solidify its dominance in the burgeoning diabetes and weight loss markets following a cascade of overwhelmingly positive clinical trial results for its blockbuster injectable Mounjaro (tirzepatide) and its highly anticipated oral GLP-1 receptor agonist, Orforglipron. The findings, which demonstrate Mounjaro's efficacy in
Eli Lilly and Company (NYSE: LLY) has announced a colossal $5 billion investment to establish a new, state-of-the-art manufacturing facility in Goochland County, Virginia. This significant expansion, a substantial increase from an initial plan of $2.148 billion, marks a pivotal moment in Lilly's strategy to bolster its domestic production
The global technology landscape is currently witnessing an unprecedented acceleration in artificial intelligence innovation, transforming industries and redefining competitive advantages. Major tech players, including Tesla (NASDAQ: TSLA), Meta Platforms (NASDAQ: META), and Salesforce (NYSE: CRM), are at the forefront of this intense AI arms race, pouring billions into research, development,
Pharmaceutical giant Eli Lilly and Company (NYSE:LLY) is gearing up for a stellar third quarter of 2025, with analysts projecting massive earnings per share (EPS) and revenue growth. The optimistic forecasts are largely fueled by the unprecedented success of its incretin-based medications, Mounjaro and Zepbound, which have become dominant
The pharmaceutical industry is witnessing an unprecedented showdown as Eli Lilly (NYSE: LLY) rapidly encroaches upon Novo Nordisk's (NYSE: NVO) long-held lead in the burgeoning GLP-1 (glucagon-like peptide-1) market. This fierce competition, fueled by blockbuster drugs for diabetes and weight loss, is not merely a corporate rivalry; it's a pivotal
Eli Lilly and Company (NYSE: LLY) has unveiled its groundbreaking TuneLab Platform, an artificial intelligence (AI) and machine learning (ML) initiative designed to democratize advanced drug discovery for biotechnology companies. This strategic move aims to level the playing field, granting smaller biotechs access to sophisticated AI models trained on decades
Eli Lilly and Company (NYSE: LLY) is making significant waves in the oncology landscape with a series of major announcements concerning two of its innovative cancer therapies: Olomorasib and Jaypirca (pirtobrutinib). Olomorasib recently secured a coveted Breakthrough Therapy Designation (BTD) from the U.S. Food and Drug Administration (FDA) for
In a highly anticipated move, the Federal Reserve delivered a 25 basis point interest rate cut in September 2025, signaling a dovish pivot in its monetary policy. This reduction, bringing the federal funds rate down to a new target range, marks a significant shift from previous stances and is widely
The financial world witnessed a landmark moment this week with the successful launch of the first U.S.-listed spot XRP ETF (XRPR) and Dogecoin ETF (DOJE) by asset manager REX-Osprey. Trading on the Cboe BZX Exchange, these new investment vehicles shattered expectations, recording impressive day-one volumes of $37.7
The U.S. Securities and Exchange Commission (SEC) has enacted a landmark policy shift, approving generic listing standards for commodity-based exchange-traded products (ETPs) that promises to revolutionize the digital asset investment landscape. Announced on September 17, 2025, by SEC Chairman Paul Atkins, this pivotal decision will dramatically fast-track the approval
Discover the top 125 family businesses in the U.S. where job seekers most want to work in 2025. From Florida hospitality firms to heritage food makers and century-old craft shops, see which companies earned the highest rankings in our nationwide survey.
The global financial landscape is navigating a complex period marked by persistent inflation, where a notable divergence in energy price trends is emerging. While crude oil and gasoline prices are showing signs of cooling, offering a potential disinflationary impulse, the costs of natural gas and electricity, particularly for residential consumers,
